Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Search results

Found 14909 matches for

Do you want to know more about Open Access? Find out about Act on Acceptance & ORCID from an expert? Book a place for our session on Tuesday 23rd August, 2-3pm in Room B at the WTCHG. Juliet Ralph, the Open Access Subject librarian, will be available for your toughest questions.

CTMGH logo for News

Tropical Immunology

The Tropical Immunology group research uses expertise in microbiology and immunology to drive understanding of how people respond to infections and vaccines. We study COVID-19, melioidosis, scrub typhus and tuberculosis, and are particularly interested in vaccine responses in people in low- and middle-income countries with diabetes, older age and immunocompromise.

Antimicrobial resistance, antimicrobial consumption and burden estimation

MICRoBE is investigating and quantifying levels and trends of antimicrobial resistance and antimicrobial consumption across the globe and over time to help inform policy and interventions. This includes quantifying health loss due to drug resistant infections (in collaboration with the Global Burden of Disease study), investigating the drivers of resistance as well as the impact of health system structures.

Drug-Resistant Infections and Disease Dynamics group

The DRIaDD group works on drug-resistant bacterial infections and other communicable disease including influenza, hepatitis E, and SARS-CoV-2.

The social science, ethics and community engagement network

Working across groups based in OCGHR and in the AAPs are a multi-disciplinary group of researchers and practitioners interested in strengthening equity and ethics in health and research initiatives involving LMICs through conducting social science research and supporting community/public engagement.

Data privacy policy

We are committed to protecting the privacy and security of your personal information. This notice describes how we collect and use your personal data submitted to us online, by email, on paper or face-to-face, in accordance with the General Data Protection Regulation (GDPR) and associated data protection legislation.

Sharing personal data with third parties

We may share your data with third parties who provide services on our behalf.

Data collected on this website

Details of the personal data we collect on this website

Contact details

Contact us if you wish to raise any queries or concerns about our use of your data

IHTM MSc, impressions of Oxford for the cohort 2020/2021

What is it like to study in Oxford in the midst of a pandemic? Check out this video of our IHTM MSc student Greco Malijan's impressions of Oxford in the first few months of the course.

Accessibility for PDFs

Acrobat Pro offers tools to create accessible PDFs and check the accessibility of existing PDFs.

Wellbeing

1. Excess Mortality during COVID-19 pandemic

The MSc in International Health and Tropical Medicine is open to candidates from a variety of academic backgrounds, both medical and non-medical.

2. The impact of the COVID-19 pandemic on vulnerable groups

3. Human rights violations during COVID-19 response

4. Challenges with implementing COVID-19 guidelines in resource-limited settings

5. Human resource challenges In the COVID-19 pandemic

6. Challenges for Reproductive, Maternal, Child, Newborn and Adolescent Health in the COVID-19 pandemic

7. Transportation and Mobility: challenges for COVID-19 pandemic control

8. Experiences from “COVID-Free” settings

Map Test

Load More

Similar stories

We gathered rich insights into child survival in Kenya by mapping patterns over 22 years

KWTRP Research

Although improvements in child survival globally have been remarkable, 5.2 million children still died in 2019, over half of these in sub-Saharan Africa. A range of factors likely include disparities in childhood immunisations, supplements and breastfeeding practices, antenatal care, skilled birth attendants working in healthcare facilities. Kenya needs to prioritise its child care plans, based on localities and populations with the greatest need. Two KWTRP studies give granular insights into the situation in regions across Kenya.

Risks of serious adverse events following treatment for visceral leishmaniasis

OCGHR Publication Research

This large-scale systematic review and meta-analysis aimed to collate all reported serious adverse events in visceral leishmaniasis clinical trials and quantify the incidence of mortality during the first 30 days of therapy. The analyses, which included clinical data from more than 35,000 patients, found that mortality following treatment was an extremely rare event and serious adverse events following treatments were poorly reported.

World TB Day: Finding new ways to test children for tuberculosis

General

Every year, over a million children fall ill with tuberculosis (TB) globally, and about a quarter die from this potentially preventable and curable disease. The main challenge remains the diagnosis of TB, especially in resource-constrained settings. We currently need to collect mucus from the lungs or liquid contents of the stomach, which must be collected in a hospital. Different ways to diagnosis TB in children are urgently needed, especially for those infected with HIV. An international collaboration is now conducting a large diagnostic study in Uganda to fill this gap. The study aims to detect TB bacteria in body fluids such as blood, urine, stool and saliva that are easier to collect.

The RECOVERY Trial: One year on

OCGHR Research

The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial was officially launched on 23 March 2020. It is the world's largest COVID-19 drug trial. Thanks to the ground-breaking work of RECOVERY, clinicians treating patients hospitalised with severe COVID-19 now have two treatments that are known to improve survival.

Researchers call for access to Ivermectin for young children

OCGHR Publication Research

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication. The WorldWide Antimalarial Resistance Network’s new meta-analysis provides evidence that supports removing this barrier and improving treatment equity.

Gender imbalance in visceral leishmaniasis clinical trials

OCGHR Publication Research

Researchers have found that despite an ongoing trend for a decreasing proportion of males being enrolled in antileishmanial therapeutic efficacy trials over time, there are still 1.8 times as many males as females involved in clinical trials. A new systematic review and meta-analysis suggests that existing knowledge on drug efficacy is derived from a study population that is heavily skewed towards adult males. At the same time, substantially less is known about the optimal treatment response in female patients.